Organ Transplant Cost by Country: Turkey, USA, UK, Germany, India

A kidney transplant is quoted from about $16,000 in Turkey and $200,000–$400,000 in the United States. Here is the organ transplant cost by country, and what each figure covers.

10.09.2026

Organ Transplant Cost by Country: Turkey, USA, UK, Germany, India

A kidney transplant is quoted from about $16,000 in Turkey and between $200,000 and $400,000 in the United States. A liver transplant from a living donor starts at $45,000–$50,000 in Turkey and at $300,000 in the United States and in Germany. Those are published 2026 market figures, and they are the reason patients start comparing countries at all.

This page puts the numbers side by side for kidney and liver transplantation, says what each figure covers, explains why the gap is as wide as it is, and sets out the part most cost pages leave out: a transplant price only becomes real once there is a donor, and no country sells one.

Kidney transplant cost by country

Each figure below is a published starting point or typical range for the transplant episode itself. None of them is a personal quote — the figure that applies to you comes from a transplant centre after a nephrologist has read your file.

CountryPublished 2026 costWhat the figure normally covers
TurkeyFrom about $16,000; Turkish providers quote $17,000–$20,000Usually quoted as a package for the transplant itself — the recipient's operation, the living donor's operation and the inpatient stay. Inclusions must be confirmed in writing.
United States$200,000–$400,000A hospital and professional-fee episode, normally settled through insurance rather than paid in cash.
United Kingdom$85,000–$150,000Private-sector pricing. Patients treated inside the NHS do not face this bill, but they enter a domestic system as domestic patients.
Germany$60,000–$150,000Treatment in a university transplant centre, normally billed to statutory or private insurance.
Canada$75,000–$130,000Hospital episode pricing; residents are covered by the public system.

Reported success rates in Turkish centres are over 95%. Price and outcome sit on different axes: a low price in an accredited high-volume centre is not evidence of a weaker result, and a high price is not evidence of a stronger one. The kidney transplant guide goes through the donor rules, the length of stay and what the Turkish figure includes.

Liver transplant cost by country

CountryPublished 2026 costWhat the figure normally covers
Turkey (living donor)From $45,000–$50,000Quoted as a package covering both the recipient and the donor operation.
IndiaFrom $20,500A starting figure for the transplant episode; inclusions vary considerably between hospitals.
United KingdomFrom $140,000Private-sector starting figure.
United StatesFrom $300,000Starting figure for the transplant episode, normally handled through insurance.
GermanyFrom $300,000Starting figure in a university transplant centre.

The Turkish liver figure is quoted for two operations, not one, and that matters when you compare. A quote that prices only the recipient is not comparable with a quote that prices the recipient and the donor together. Turkish centres report success rates of 95–97%, with five-year survival of 60–70%; some recipients live more than 30 years after transplant. Hospital stay is 2–3 weeks and the total stay in Turkey is about a month or longer, which is a cost in itself. Living-donor liver transplantation covers the clinical side.

Why the gap is this large — and why it is not “cheaper surgeons”

The first explanation people reach for is that a $17,000 operation must be a lesser version of a $250,000 one. That is the wrong explanation, and believing it leads to the wrong safety checks.

  • Operating costs. Salaries across the whole team, the building, the supporting staff and the general price level of the country all sit inside a hospital bill. The same procedure carries a different fixed cost base in Ankara than in Boston, before anyone touches a patient.
  • Case volume in specialised centres. Transplantation is concentrated in a small number of centres that do it repeatedly. Volume spreads the cost of the theatre, the intensive-care capacity and the transplant team across many cases rather than a few.
  • Competition between accredited centres for the same international patients. Several accredited Turkish centres are quoting to the same pool of foreign patients each month. That pressure sits on the quoted price in a way it does not in a system where transplantation is funded domestically and there is no international list price at all.

What does not explain the gap is a discount on the surgeon, on the immunosuppression protocol or on the intensive-care stay. Those are the parts of a transplant that cannot be thinned out without the outcome showing it. If a quote is low because those were removed, that is not a cheaper country — that is a worse offer, and it can appear in any country. The check that matters is the centre's accreditation, its transplant volume and its licence, not the size of the number.

A transplant price is meaningless without a donor

This is the section that changes plans, and it is the reason a cost comparison can be actively misleading. Comparing countries answers the question “what would it cost?” It does not answer “can it happen?” — and for most foreign patients the second question is the blocking one.

Turkey's deceased-donor allocation system is built around patients inside the Turkish health system. A non-resident cannot realistically obtain a place on it, and money does not change allocation order. Living donation is the route for a foreign patient, which means the donor travels with the patient. A foreign patient with no eligible living donor does not get a shorter route by choosing a cheaper country; they get the same wait, in a different currency.

Turkish law — Law No. 2238 of 29 May 1979 and the Organ and Tissue Transplantation Services Regulation — allows living donation on kinship alone where donor and recipient are related within the fourth degree of blood or marriage kinship inclusive, or are spouses who have lived together for at least two years. Outside that circle, an ethics commission reviews the case. For foreign nationals, under Law No. 6458 of 4 April 2013, ethics-commission review is required regardless of kinship: a Turkish citizen receiving a kidney from his brother needs no commission, a foreign patient whose brother donates still does. Buying, selling or brokering an organ is a criminal offence, and a patient who takes part in it is not a bystander. The legal guide for foreign patients sets out what the commission reads and how long it takes.

What no quote in any country includes

Every headline figure on this page describes the hospital episode. The budget a family actually needs is larger, in every country, by roughly the same categories:

  • Flights — for the patient, the donor, and usually one accompanying person, sometimes at short notice.
  • Accommodation for weeks, not days. A liver transplant means about a month or longer in the country. That is rent, food and local transport for two or three people.
  • The donor's own workup and recovery. The donor is screened before anything is approved, and then needs time. After laparoscopic donor nephrectomy, discharge is at 1–2 days and return to work takes 2–6 weeks depending on the job. A liver donor is in hospital about a week and back to regular activities in six to eight weeks. Lost income during that period is a real cost that no package line covers.
  • Lifelong immunosuppression. The medication starts in hospital and does not stop. Its price and availability in your own country is a question to settle before the operation — see life after a transplant.
  • A reserve for readmission. Rejection episodes, infections and surgical complications happen, and they happen after the package ends. A contingency of a meaningful size, held in cash, is part of a serious plan.

How to make two quotes comparable

Two figures from two countries are almost never describing the same thing. Send the same written questions to every centre and compare the answers, not the totals:

  • Does this figure cover the donor's operation and the donor's hospital stay, or only the recipient's?
  • Does it cover the donor's pre-operative workup, and what happens to the cost if the donor is screened and then found unsuitable?
  • How many days of intensive care and inpatient stay are included, and what is the daily rate beyond that?
  • Are the immunosuppressants for the hospital stay and for the first weeks after discharge included, and for how long?
  • What happens financially if the patient is readmitted within 30 or 90 days — is a complication treated inside the package or billed separately?
  • Are the ethics-commission documentation, translations and any legal fees inside the figure?
  • What is excluded in writing? A centre that answers this in a list is easier to trust than one that answers it in adjectives.

Any quote that cannot survive those seven questions in writing is not a price, it is an advertisement.

When travelling for a transplant is the wrong plan

There are situations where the honest answer is that no country on this table helps, and a cost comparison is a distraction.

If there is no eligible living donor, the cheapest country in the world does not change anything, and any party who suggests it does is offering something illegal. If the patient is already listed on a deceased-donor programme at home with a realistic prospect of an offer, leaving that list to travel can be a losing trade — and that decision belongs to the treating nephrologist or hepatologist, not to a price table. If the patient is medically unstable, if the underlying disease is not controlled, or if there is active infection or untreated malignancy, the transplant centre will not accept the case regardless of budget, and it is better to hear that before booking flights.

It is also the wrong plan when the follow-up cannot be arranged. A transplant performed well abroad and then followed up nowhere is a poor outcome waiting to happen. If the immunosuppressants are unaffordable or unavailable at home, or no local specialist has agreed to take the case, that has to be solved first — otherwise the money saved on the operation is spent later, on losing the graft. For kidney patients weighing the whole picture rather than the surgery alone, dialysis or transplant is the comparison that matters more than country against country.

Frequently asked questions

Why is a kidney transplant so much cheaper in Turkey than in the USA?
Because of operating costs, case volume in specialised centres and competition between accredited centres for the same international patients — not because the surgery is a reduced version of itself. The parts of a transplant that determine outcome are the parts that cannot be cut.

Can I buy a kidney or a liver in Turkey?
No. Buying, selling or brokering an organ is a criminal offence in Turkey and the patient taking part is treated as a participant, not a victim. Foreign patients must bring their own living donor, and the relationship is examined by an ethics commission.

Is India cheaper than Turkey for a liver transplant?
The published starting figures are lower in India — from $20,500 against $45,000–$50,000 in Turkey. The figures are not describing identical packages: the Turkish figure is quoted for the recipient and the donor together. Compare inclusions in writing before comparing totals.

Does a cheaper country mean a shorter wait?
No. For a foreign patient the route is living donation, so the timeline is set by donor eligibility, medical screening and ethics-commission review — not by the price of the operation.

What should I add to the quoted price when budgeting?
Flights for patient and donor, several weeks of accommodation, the donor's workup and lost income during recovery, lifelong immunosuppressants at home-country prices, and a cash reserve for readmission.

Does MedAgent publish a transplant price?
No. The figure comes from the transplant centre after a nephrologist or hepatologist has read the medical file. What we can say before that is whether the donor situation is workable under Turkish rules.

Prices on this page are approximate 2026 market data and change with exchange rates and clinic policy. This page is general information, not medical or legal advice; eligibility, technique and outcome are determined individually by a licensed physician.

Not sure where to start?

Send us what you already have — the pathology report, imaging on disc, discharge summaries. A specialist at a partner hospital will review it and tell you what is realistic in your case and how quickly treatment could begin. Reviewing your documents costs nothing and commits you to nothing.

Send your documents

Recent Posts